With so many Bible translations available, how do you choose the right one? This video dives into the complexities of translation, exploring the King James Version, NIV, NRSV, and more. We break down ...

Respiratory syncytial virus (RSV) is a common, highly contagious illness that affects the nose, throat, and lungs. Although RSV usually causes mild illness with cold-like symptoms, the infection can ...

Opens in a new tab or window During last year's respiratory virus season, newly approved vaccines for respiratory syncytial virus (RSV) were effective in preventing associated hospitalizations and ...

Opens in a new tab or window The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years and older, as well as for 60- to 74-year ...

Respiratory syncytial virus (RSV) has been known to cause a rash in addition to the more common symptoms of a runny nose, coughing, and wheezing. However, an RSV rash is rare. This article explores ...

Another completely reliable source is the U.S. Centers for Disease Control and Prevention (cdc.gov). You can find ...

Three months after revealing that its respiratory syncytial virus (RSV) preventive antibody clesrovimab had passed muster in a phase 2b/3 trial, Merck is putting numbers to the claim. Clesrovimab ...

In years prior to the availability of an RSV vaccine, an estimated 60,000 to 160,000 RSV-associated hospitalizations and 6,000 to 10,000 RSV-associated deaths occurred annually among U.S. adults ...

Pfizer’s bivalent RSV prefusion F vaccine has been approved to prevent lower respiratory tract disease resulting from the respiratory syncytial virus in adults 18 to 59 years of age who are at ...

The seasonal shot met its primary goal in the mid-to-late stage trial, reducing the incidence of RSV-associated, medically attended lower respiratory infections in healthy infants up to one year ...